Philip D. Hall - Concepedia

Author

Philip D. Hall

Medical University of South Carolina

Also Known As

P Hall, P. Hall, Philip D Hall, Philip D. Hall, Philip Hall

Publications

413

Citations

H-Index

Concepts

All Affiliations

Medical University of South Carolina MUSC Hollings Cancer Center

About

Philip D. Hall is an author at Medical University of South Carolina specializing in medicine, cell signaling, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	80
2	Public Health	1	1	54
3	Cell Biology	1	1	12
4	Immunology	1	1	12
5	Obstetrics	1	1	54

Philip D. Hall

Publications

385

Citations

H-Index

Page 1

	Year	Citations
Shrinkage of cutaneous specimens: formalin or other factors involved? Mary Jo Kerns, Marc A. Darst, Thomas G. Olsen, Journal of Cutaneous Pathology	2008	135
A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia. Arthur E. Frankel, Donald R. Fleming, Philip D. Hall, PubMed	2003	73
Treatment of Acute Myeloid Leukemia During the Second and Third Trimesters of Pregnancy Dawn M. Niedermeier, Debra Frei‐Lahr, Philip D. Hall Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy Hematological MalignancyMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaVentricular Septal DefectHematology	2005	54
Overexpression of p53 in Hodgkin's disease: Lack of correlation with Epstein–Barr virus infection Gerald Niedobitek, David C. Rowlands, Lawrence S. Young, The Journal of Pathology	1993	36
Fentanyl‐Associated Syndrome of Inappropriate Antidiuretic Hormone Secretion Heather Kokko, Philip D. Hall, Lawrence B. Afrin Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2002	31
A Phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma Edward F. McClay, Mary-Eileen T. McClay, Jeffrey A. Jones, Cancer	1997	20
High dose combination chemotherapy with ifosfamide, cyclophosphamide or cisplatin, mitomycin C and mustine with autologous bone marrow support in advanced non-small cell lung cancer. A phase I/II study SA Gomm, N. Thatcher, Andrew Cuthbert, British Journal of Cancer Phase I/ii StudyMedicinePathologyBronchial NeoplasmCancer Treatment	1991	14
Ricin fusion toxin targeted to the human granulocyte-macrophage colony stimulating factor receptor is selectively toxic to acute myeloid leukemia cells Chris Burbage, Edward P. Tagge, Billie Harris, Leukemia Research ImmunotoxicologyGranulocyteMedicineMalignant Blood DisorderImmunology	1997	12
A Continuous Quality Improvement Program to Focus a College of Pharmacy on Programmatic Advancement Philip D. Hall, Joseph T. DiPiro, Randall C. Rowen, American Journal of Pharmaceutical Education	2013	10

Page 1